Feng Zhaohui, Hu Wenwei, Rajagopal Gunaretnam, Levine Arnold J
Cancer Institute of New Jersey, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey, USA.
Cell Cycle. 2008 Apr 1;7(7):842-7. doi: 10.4161/cc.7.7.5657. Epub 2008 Jan 23.
Aging, like many other biological processes, is subject to regulation by genes that reside in pathways that have been conserved during evolution. The insulin/ IGF-1 pathway, mTOR pathway and p53 pathway are among those conserved pathways that impact upon longevity and aging-related diseases such as cancer. Most cancers arise in the last quarter of life span with the frequency increasing exponentially with time, and mutation accumulation in critical genes (e.g., p53) in individual cells over a lifetime is thought to be the reason. Recently, we found that the efficiency of the p53 response to stress declines significantly with age in mice, and the time of onset of this decreased p53 response correlates with the life span of mice. Given the crucial role of the p53 in tumor prevention, this decline in p53 activity at older ages in animals could contribute to the observed dramatic increases in cancer frequency, and provides a plausible explanation for the correlation between tumorigenesis and aging in addition to the accumulation of DNA mutations over lifetime. We discuss here the coordination and communication between the p53 pathway and the IGF-1-mTOR pathways, and their possible impact on cancer and longevity.
衰老与许多其他生物过程一样,受到进化过程中保守的基因通路的调控。胰岛素/胰岛素样生长因子-1(IGF-1)通路、哺乳动物雷帕霉素靶蛋白(mTOR)通路和p53通路就是这些影响寿命和衰老相关疾病(如癌症)的保守通路。大多数癌症发生在寿命的后四分之一阶段,且发病率随时间呈指数增长,人们认为这是由于个体细胞在一生中关键基因(如p53)的突变积累所致。最近,我们发现小鼠中p53对应激的反应效率随年龄显著下降,这种p53反应降低的起始时间与小鼠的寿命相关。鉴于p53在肿瘤预防中的关键作用,动物衰老时p53活性的下降可能导致观察到的癌症发病率急剧上升,除了一生中DNA突变的积累外,这也为肿瘤发生与衰老之间的相关性提供了一个合理的解释。我们在此讨论p53通路与IGF-1-mTOR通路之间的协调与沟通,以及它们对癌症和寿命可能产生的影响。